Editorial invitation · JAPST
The Journal of Advanced Pharmaceutical Science and Technology (JAPST), a peer-reviewed open-access journal, welcomes submissions to its regular issues throughout the year from researchers and practitioners working across pharmaceutical science, technology and practice.
Release profile
A submission should make a clear contribution to pharmaceutical knowledge, technology, medicine safety or pharmacy practice. A new formulation or manufacturing process is not required for every study.
Medicinal chemistry, drug and prodrug design, lead identification and optimization, structure–activity relationships, target validation and computational drug discovery. Chemical and molecular studies should establish their relevance to a drug, therapeutic target or pharmaceutical problem.
Drug mechanisms, pharmacodynamics, dose–response relationships, pharmacokinetics, absorption, distribution, metabolism and excretion, drug interactions, safety pharmacology and toxicology. Studies may address experimental systems or clinical drug response without requiring formulation innovation.
Phytochemistry, medicinal natural products, bioactive constituents, herbal medicines and ethnopharmacology with a defined pharmaceutical question. Work may examine identity, composition, biological activity, safety, standardization or quality, using authenticated materials and methods appropriate to the claims.
Preformulation, physical pharmacy, excipients, dosage forms, controlled and targeted delivery, nanomedicines and pharmaceutical biomaterials. Biopharmaceutics includes dissolution, permeability, bioavailability, bioequivalence and relationships between drug properties, dosage forms and biological performance.
Analytical method development and validation, drug and metabolite measurement, impurity and adulterant detection, stability-indicating assays, spectroscopy, chromatography, dissolution testing and process analytical technology. Methods should be evaluated for their intended pharmaceutical or bioanalytical use.
Process development, pharmaceutical engineering, scale-up, continuous manufacturing, stability, packaging, quality control and assurance, quality by design, validation and technology transfer. Regulatory science includes evidence and methods supporting pharmaceutical quality, safety, efficacy and regulatory evaluation.
Therapeutic proteins, peptides, antibodies, vaccines and nucleic-acid therapeutics; their discovery, biological evaluation, characterization, formulation, delivery or production. Biotechnology and bioinformatics fit when the pharmaceutical application is part of the research question.
JAPST also welcomes clinical pharmacology, pharmacotherapy, therapeutic drug monitoring, pharmacogenetics and pharmacogenomics, pharmacovigilance, pharmacoepidemiology and pharmacoeconomics. Clinical, hospital, community, social and public-health pharmacy studies may address prescribing, drug utilization, adherence, interactions, access to medicines, medication safety or pharmaceutical-care services. Their contribution can concern the use and effects of existing medicines; a new product or formulation is not a condition of scope.
Choose the format that matches the contribution. Clinical and observational study designs are included within original research.
Experimental, analytical, computational, clinical, observational and pharmacy-practice studies addressing a defined pharmaceutical question.
Critical narrative reviews, focused reviews, systematic reviews and meta-analyses with a clear question, transparent methods and balanced interpretation.
Well-documented cases concerning adverse drug reactions, interactions, medication errors, pharmacotherapy or pharmaceutical care, with appropriate consent and cautious interpretation.
Concise reports of a focused finding or method, with enough evidence to support the stated contribution.
Pharmaceutical methods or study protocols with a clear rationale, sufficient methodological detail and evaluation appropriate to their purpose.
Evidence-based scholarly discussion of pharmaceutical science, technology, regulation, medicine use or pharmacy practice.
The journal evaluates scope, scientific quality, methodological rigor, ethical compliance, reporting quality and relevance.
Peer review: Single-blind by default; double-blind review is available on request.
Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Use only one approved route for the same manuscript.
Submit and manage the manuscript in the publisher's editorial system.
Open ManuscriptZoneUse the publisher's manuscript submission form.
Open submission formEmail the manuscript and supporting files to [email protected].
Email the editorial officeAuthors must use only one submission route for the same manuscript.